Health
COVID-19 vaccine candidate is 96.4 percent effective in mice, study shows – Drug Target Review
Administering two doses of a COVID-19 vaccine called BVX-0320 is effective in mouse models, a pre-clinical study has shown.
Posted: 1 December 2020 | Victoria Rees (Drug Target Review) | No comments yet
Administering two doses of a COVID-19 vaccine called BVX-0320 is effective in mouse models, a pre-clinical study has shown.
A new COVID-19 vaccine candidate has shown success in mouse models by inducing high levels of antibodies against the S1 fragment of the SARS-CoV-2 Spike (S) protein.
Developed by BioVaxys Technology, the vaccine, called BVX-0320, did not produce any toxicity in the mice. According to the researchers,…
-
Noosa News21 hours agoBob Katter threatens to punch Nine reporter during ant-immigration press conference
-
Business24 hours agoThis ASX 200 healthcare stock crashed 14% to 4-year low. Here’s what happened
-
Business20 hours agoDicker Data rides the AI trend to double digit growth
-
Noosa News21 hours agoBob Katter threatens Channel 9 journalist for asking question on family heritage